1. Home
  2. PROC vs XBIT Comparison

PROC vs XBIT Comparison

Compare PROC & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROC
  • XBIT
  • Stock Information
  • Founded
  • PROC 1976
  • XBIT 2005
  • Country
  • PROC Luxembourg
  • XBIT United States
  • Employees
  • PROC N/A
  • XBIT N/A
  • Industry
  • PROC Biotechnology: Pharmaceutical Preparations
  • XBIT Pharmaceuticals and Biotechnology
  • Sector
  • PROC Health Care
  • XBIT Health Care
  • Exchange
  • PROC Nasdaq
  • XBIT Nasdaq
  • Market Cap
  • PROC 203.1M
  • XBIT 211.9M
  • IPO Year
  • PROC N/A
  • XBIT 2015
  • Fundamental
  • Price
  • PROC $2.55
  • XBIT $6.27
  • Analyst Decision
  • PROC
  • XBIT
  • Analyst Count
  • PROC 0
  • XBIT 0
  • Target Price
  • PROC N/A
  • XBIT N/A
  • AVG Volume (30 Days)
  • PROC 136.7K
  • XBIT 72.1K
  • Earning Date
  • PROC 02-15-2025
  • XBIT 11-13-2024
  • Dividend Yield
  • PROC N/A
  • XBIT N/A
  • EPS Growth
  • PROC N/A
  • XBIT N/A
  • EPS
  • PROC 0.52
  • XBIT N/A
  • Revenue
  • PROC $414,096,000.00
  • XBIT N/A
  • Revenue This Year
  • PROC $5.54
  • XBIT N/A
  • Revenue Next Year
  • PROC $8.54
  • XBIT N/A
  • P/E Ratio
  • PROC $4.87
  • XBIT N/A
  • Revenue Growth
  • PROC N/A
  • XBIT N/A
  • 52 Week Low
  • PROC $0.50
  • XBIT $3.83
  • 52 Week High
  • PROC $4.95
  • XBIT $9.96
  • Technical
  • Relative Strength Index (RSI)
  • PROC 57.57
  • XBIT 42.25
  • Support Level
  • PROC $2.40
  • XBIT $6.06
  • Resistance Level
  • PROC $3.78
  • XBIT $7.24
  • Average True Range (ATR)
  • PROC 0.46
  • XBIT 0.51
  • MACD
  • PROC 0.09
  • XBIT -0.03
  • Stochastic Oscillator
  • PROC 55.63
  • XBIT 17.72

About PROC Procaps Group S.A.

Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.

About XBIT XBiotech Inc.

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.

Share on Social Networks: